Long‐term safety and efficacy of levodopa‐carbidopa intestinal gel in advanced Parkinson's disease

ABSTRACT Background: Levodopa‐carbidopa intestinal gel (designated as carbidopa‐levodopa enteral suspension in the United States) provides stable plasma levodopa concentrations and reduces motor fluctuations in advanced Parkinson's disease patients through continuous delivery of levodopa via pe...

Full description

Saved in:

Bibliographic Details
Published in:	Movement disorders Vol. 33; no. 6; pp. 928 - 936
Main Authors:	Fernandez, Hubert H., Boyd, James T., Fung, Victor S. C., Lew, Mark F., Rodriguez, Ramon L., Slevin, John T., Standaert, David G., Zadikoff, Cindy, Vanagunas, Arvydas D., Chatamra, Krai, Eaton, Susan, Facheris, Maurizio F., Hall, Coleen, Robieson, Weining Z., Benesh, Janet, Espay, Alberto J.
Format:	Journal Article
Language:	English
Published:	United States 01.07.2018
Subjects:	Adult Aged Aged, 80 and over Antiparkinson Agents - therapeutic use Carbidopa - therapeutic use Compulsive Behavior - chemically induced Compulsive Behavior - epidemiology Double-Blind Method Drug Combinations Female Gels - therapeutic use Humans infusion International Cooperation Intestines - physiology Levodopa - therapeutic use levodopa‐carbidopa intestinal gel Longitudinal Studies Male Middle Aged Outcome Assessment (Health Care) Parkinson Disease - drug therapy Parkinson's disease percutaneous endoscopic gastrojejunostomy Polyneuropathies - chemically induced Polyneuropathies - epidemiology safety Weight Loss - drug effects levodopa-carbidopa intestinal gel Parkinson's disease infusion percutaneous endoscopic gastrojejunostomy safety
ISSN:	0885-3185, 1531-8257, 1531-8257
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!